BioSpace News Archive

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 12, 2023, at 9:00 am PST.

Merck, known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, February 2.

BD, a leading global medical technology company, released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022, among 872 U.S. women ages 18 to 64 years old, that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.

Synlogic, Inc., a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, summarized accomplishments for 2022 and outlined anticipated key milestones for 2023.

TScan Therapeutics, Inc. announced its 2023 clinical pipeline plans and highlighted recent corporate achievements.

IN8bio, Inc., a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, announced a clinical update from the ongoing Phase 1 trial evaluating INB-200 in patients with newly diagnosed GBM and provided pipeline goals for 2023.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, announced a comprehensive update on its future clinical development plans.

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced the appointment of Massoud Motamed, Ph.D., as Vice President of Quality.

Neogen Corporation announced the results of the second quarter ended November 30, 2022.

Esperovax, an innovative developer of oral mRNA biologics, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, announced a partnership to develop circular RNAs for a variety of therapeutic applications.